Outcome of Patients With C-Myc Rearranged Diffuse Large B Cell Lymphoma Associated or Not With Bcl2 and/or Bcl6 Rearrangement: A Multicentric and Retrospective Study

Hematological Oncology - United Kingdom
doi 10.1002/hon.17_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

PLoS ONE
Multidisciplinary
2014English

Clinical Significance and Outcomes in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Harboring Extra Copies [Ec] and/or Translocations [Tl] of Myc, Bcl2, and Bcl6

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Distinction Between Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma With C-Myc Rearrangement

Modern Pathology
Forensic MedicinePathology
2002English

P53 Expression Correlates With Poorer Survival and Augments the Negative Prognostic Effect of MYC Rearrangement, Expression or Concurrent MYC/BCL2 Expression in Diffuse Large B-Cell Lymphoma

Modern Pathology
Forensic MedicinePathology
2016English

Detailed Molecular Analysis and Evaluation of Prognosis in Cases With High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements

British Journal of Haematology
Hematology
2018English

Targeting MYC Activity in Double-Hit Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements With Epigenetic Bromodomain Inhibitors

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

BCL2 mRNA or Protein Abundance Is Superior to Gene Rearrangement Status in Predicting Clinical Outcomes in Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

C-Myc and BCL2: Correlation Between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma

Asian Pacific Journal of Cancer Prevention
2019English

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Annals of Hematology
MedicineHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy